RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative Glioblastoma.
Clin Cancer Res
; 27(2): 645-655, 2021 01 15.
Article
in En
| MEDLINE
| ID: mdl-33106291
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Immunohistochemistry
/
Biomarkers, Tumor
/
Sequence Analysis, RNA
/
Glioblastoma
/
Kruppel-Like Transcription Factors
Type of study:
Prognostic_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Cancer Res
Journal subject:
NEOPLASIAS
Year:
2021
Document type:
Article
Affiliation country:
Spain
Country of publication:
United States